We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
PROMIS depression measures perform similarly to legacy measures relative to a structured diagnostic interview for depression in cancer patients.
- Authors
Clover, Kerrie; Lambert, Sylvie D.; Oldmeadow, Christopher; Britton, Benjamin; King, Madeleine T.; Mitchell, Alex J.; Carter, Gregory
- Abstract
<bold>Purpose: </bold>To assess the convergent validity of the Patient-Reported Outcomes Measurement Information System (PROMIS) depression measures relative to legacy measures and criterion validity against a structured diagnostic interview for depression in an oncology sample.<bold>Methods: </bold>132 oncology/haematology outpatients completed the PROMIS Depression Computer Adaptive Test (PROMIS-D-CAT) and PROMIS Depression Short Form (PROMIS-D-SF) along with seven legacy measures: Beck Depression Inventory (BDI); Centre for Epidemiological Studies Depression (CES-D); Depression, Anxiety and Stress Scale; Hospital Anxiety and Depression Scale; Patient Health Questionnaire; Distress Thermometer and PSYCH-6. Correlations, area under the curve (AUC) and diagnostic accuracy statistics were calculated with Structured Clinical Interview as the gold standard.<bold>Results: </bold>Both PROMIS measures correlated with all legacy measures at p < .001 (ρ = 0.589-0.810) and all AUCs (> 0.800) were comparable. At the cut-off points for mild depression of 53, the PROMIS measures had sensitivity (0.83 for PROMIS-D-CAT and 0.80 for PROMIS-D-SF) similar to or better than 6/7 legacy measures with high negative predictive value (> 90%). At cut-off points of 60 for moderate depression, PROMIS measures had specificity > 90%, similar to or better than all legacy measures and positive predictive value ≥ 0.50 (similar to 5/7 legacy measures).<bold>Conclusions: </bold>The convergent and criterion validity of the PROMIS depression measures in cancer populations was confirmed, although the optimal cut-off points are not established. PROMIS measures were briefer than BDI-II and CES-D but do not offer any advance in terms of diagnostic accuracy, reduced response burden or cost over other legacy measures of depression in oncology patients.
- Subjects
CANCER patient psychology; HEALTH of cancer patients; MENTAL depression; ANXIETY; HEALTH outcome assessment; RESEARCH evaluation; CANCER patients; EXPERIMENTAL design; RESEARCH methodology; RESEARCH funding; STATISTICAL sampling; STATISTICS; LOGISTIC regression analysis; DATA analysis
- Publication
Quality of Life Research, 2018, Vol 27, Issue 5, p1357
- ISSN
0962-9343
- Publication type
journal article
- DOI
10.1007/s11136-018-1803-x